Add BrightSurf on Google Email

Science News Archive June 2019 - Page 41


Page 41 of 41

Ribociclib plus hormone therapy extends survival for patients with premenopausal advanced hormone receptor-positive breast cancer

The MONALEESA-7 Phase III trial found that adding ribociclib to hormone therapy significantly improved overall survival in premenopausal patients with advanced HR+ breast cancer, with a 29% lower risk of death. The combination was well-tolerated, with no new side effects emerging.

SourceUniversity of Texas M. D. Anderson Cancer Center·JournalNew England Journal of Medicine·DateJun 1, 2019

Virtual reality improves tolerance of anaesthesia procedures and reduces need for intravenous sedation by at least 50%

A new study finds that virtual reality hypnosis distraction (VRHD) can reduce anxiety and procedure-related pain during locoregional anaesthesia for orthopaedic procedures. The randomised trial shows a significant reduction in the need for intravenous sedation, with 25% of patients requiring no further sedation.